Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder

Area of Science:

• Biochemistry
• Oncology
• Pharmacology

Background:

• Xenobiotic metabolizing enzymes (XMEs) are crucial for drug detoxification.
• These enzymes, including cytochromes P450 (CYPs), epoxide hydrolase (EH), and glutathione S-transferases (GSTs), may influence anti-cancer drug efficacy.
• Understanding their expression in tumors is vital for personalized medicine.

Purpose of the Study:

• To investigate the cell-specific expression of individual XMEs in primary transitional cell tumors of the urinary bladder.
• To determine the correlation between XME expression and bladder tumor grade.
• To compare XME expression in tumor tissues versus normal bladder tissue.

Main Methods:

• Immunohistochemistry was employed to detect the expression of specific XMEs.
• Primary transitional cell tumors of the urinary bladder and normal bladder tissues were analyzed.
• Expression levels of CYP1A, CYP2C, CYP3A, EH, and GSTs (alpha, mu, pi forms) were quantified.

Main Results:

• CYP1A, CYP2C, and CYP3A were detected in 68%, 28%, and 68% of tumors, respectively.
• EH was identified in 84% of tumors; GST alpha, mu, and pi forms were expressed in 56%, 72%, and 52% of tumors, respectively.
• CYP1A expression significantly correlated with bladder tumor grade (P = 0.03).
• Normal bladder tissue primarily expressed EH and GST pi, with no detectable CYP2C expression.

Conclusions:

• Significant expression of various XMEs, including CYP1A, CYP3A, EH, and GSTs, occurs in transitional cell tumors of the urinary bladder.
• The correlation between CYP1A expression and tumor grade suggests its potential role in bladder cancer progression.
• Differential expression patterns of XMEs in tumors versus normal tissue highlight their potential as therapeutic targets or biomarkers for anti-cancer drug response.